ICU Medical (NASDAQ:ICUI) Lowered to “Hold” at StockNews.com

ICU Medical (NASDAQ:ICUIGet Rating) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday.

A number of other research firms have also weighed in on ICUI. Zacks Investment Research raised ICU Medical from a “hold” rating to a “buy” rating and set a $245.00 price objective for the company in a research note on Wednesday, April 27th. Raymond James dropped their price objective on ICU Medical from $286.00 to $265.00 and set an “outperform” rating for the company in a research note on Monday, February 28th. One analyst has rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $263.33.

NASDAQ ICUI opened at $175.26 on Thursday. The company has a market capitalization of $4.19 billion, a PE ratio of 85.91 and a beta of 0.48. The company has a debt-to-equity ratio of 0.75, a quick ratio of 3.68 and a current ratio of 2.38. The business’s fifty day moving average is $219.67 and its 200 day moving average is $225.33. ICU Medical has a fifty-two week low of $167.47 and a fifty-two week high of $282.00.

ICU Medical (NASDAQ:ICUIGet Rating) last released its quarterly earnings data on Monday, May 9th. The medical instruments supplier reported $1.82 earnings per share for the quarter, topping analysts’ consensus estimates of $1.78 by $0.04. The firm had revenue of $543.10 million during the quarter, compared to analyst estimates of $557.33 million. ICU Medical had a return on equity of 7.89% and a net margin of 2.68%. The business’s quarterly revenue was up 70.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.34 earnings per share. On average, sell-side analysts forecast that ICU Medical will post 8.61 EPS for the current year.

In other ICU Medical news, VP Virginia Ruth Sanzone sold 750 shares of the company’s stock in a transaction that occurred on Thursday, May 12th. The stock was sold at an average price of $173.56, for a total transaction of $130,170.00. Following the sale, the vice president now directly owns 3,371 shares in the company, valued at $585,070.76. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Vivek Jain sold 36,000 shares of the company’s stock in a transaction that occurred on Thursday, March 3rd. The shares were sold at an average price of $240.00, for a total value of $8,640,000.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 36,967 shares of company stock valued at $8,807,175. 7.30% of the stock is owned by corporate insiders.

A number of hedge funds have recently modified their holdings of the business. Equitable Trust Co. boosted its position in ICU Medical by 3.7% during the 4th quarter. Equitable Trust Co. now owns 1,307 shares of the medical instruments supplier’s stock valued at $310,000 after acquiring an additional 47 shares in the last quarter. State of Michigan Retirement System boosted its position in shares of ICU Medical by 1.0% in the 1st quarter. State of Michigan Retirement System now owns 5,061 shares of the medical instruments supplier’s stock worth $1,127,000 after purchasing an additional 52 shares in the last quarter. Arizona State Retirement System grew its stake in ICU Medical by 1.0% during the 3rd quarter. Arizona State Retirement System now owns 5,491 shares of the medical instruments supplier’s stock worth $1,281,000 after buying an additional 53 shares during the last quarter. Quadrant Capital Group LLC increased its position in ICU Medical by 81.5% during the 1st quarter. Quadrant Capital Group LLC now owns 118 shares of the medical instruments supplier’s stock valued at $26,000 after buying an additional 53 shares in the last quarter. Finally, Exchange Traded Concepts LLC raised its stake in ICU Medical by 1.8% in the fourth quarter. Exchange Traded Concepts LLC now owns 3,059 shares of the medical instruments supplier’s stock valued at $726,000 after buying an additional 54 shares during the last quarter. Institutional investors and hedge funds own 94.93% of the company’s stock.

About ICU Medical (Get Rating)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs.

See Also

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.